NCT05055336

Brief Summary

The purpose of this research is to further study the relationship between gastroparesis (GP) (a condition in which the stomach cannot empty itself of food in a normal fashion) and functional dyspepsia (FD) (frequent symptoms of indigestion that have no obvious cause).

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2022

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 24, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

October 10, 2022

Status Verified

October 1, 2022

Enrollment Period

11 months

First QC Date

August 23, 2021

Last Update Submit

October 6, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gastric emptying rate

    As measured by the spirulina breath test

    up to 6 months

Secondary Outcomes (2)

  • Percentage of food retained in the stomach

    Day 1

  • Pediatric Cardinal Symptoms Questionnaire Scores

    Up to 6 months

Study Arms (3)

Gastroparesis

EXPERIMENTAL

Participants in this group are children diagnosed with gastroparesis per gastric emptying scintigraphy. Participants will be receiving a gastric emptying breath test three times over the course of 6 months and an ultrasound of the stomach once.

Other: Gastric emptying breath testOther: Stomach ultrasound

Dyspepsia

EXPERIMENTAL

Participants in this group are children diagnosed with functional dyspepsia per gastric emptying scintigraphy. Participants will be receiving a gastric emptying breath test three times over the course of 6 months and an ultrasound of the stomach once.

Other: Gastric emptying breath testOther: Stomach ultrasound

Healthy Controls

EXPERIMENTAL

Participants in this group are children that do not have gastroparesis, functional dyspepsia, or any other gastroenterology condition. Participants will be getting an ultrasound once.

Other: Stomach ultrasound

Interventions

The gastric emptying breath test is used to diagnose gastroparesis. Participants ingest spirulina in a meal and samples are taken every 45 minutes for 4 hours.

DyspepsiaGastroparesis

Ultrasound of the fundus of the stomach will be done immediately after ingestion of the test meal, at 15 minutes, and at 30 minutes.

DyspepsiaGastroparesisHealthy Controls

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Able to complete the Pediatric Cardinal Symptoms Questionnaire
  • Both parent and child must be able to speak and understand English or Spanish

You may not qualify if:

  • Have global developmental delay, autism disorder, or psychosis
  • Are nonverbal and/or illiterate
  • Lack fluency in English or Spanish
  • Have a history of surgical procedures that could have potentially affected their GI tract anatomy, such as fundoplication or Ladd's procedure.
  • Healthy child presenting to their well child care visit must not report a history of dyspepsia, have a history of any gastrointestinal disease, or be taking any medication that can disturb the GI tract motility.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

GastroparesisDyspepsia

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Study Officials

  • Liz Febo-Rodriguez, MD

    University of Miami

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2021

First Posted

September 24, 2021

Study Start

May 1, 2022

Primary Completion

April 1, 2023

Study Completion

April 1, 2023

Last Updated

October 10, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share